Trials
ClinicalTrials.gov
Search clinical trials by condition, drug, outcome or NCT number, with the results each one posted.
193,990 genes from NCBI Gene.
Most papers first3,481 to 3,500 of 193,990
| Gene | NCBI Gene | Proteins | Patents | Drugs | Trials | NIH grants | Papers |
|---|---|---|---|---|---|---|---|
| NKG7 natural killer cell granule protein 7 | 4818 HGNC:7830 | 1 | 38 | 0 | 0 | 1,401 | 1,677 |
| EPHA3 EPH receptor A3 | 2042 HGNC:3387 | 1 | 93 | 2 | 99 | 1,326 | 1,673 |
| TUBA1A tubulin alpha 1a | 7846 HGNC:20766 | 1 | 66 | 90 | 8,728 | 1,314 | 1,672 |
| PCBP1 poly(rC) binding protein 1 | 5093 HGNC:8647 | 1 | 41 | 0 | 0 | 1,103 | 1,671 |
| ASNS asparagine synthetase (glutamine-hydrolyzing) | 440 HGNC:753 | 1 | 48 | 0 | 0 | 1,237 | 1,669 |
| SRGN serglycin | 5552 HGNC:9361 | 1 | 66 | 0 | 0 | 777 | 1,669 |
| BMPER BMP binding endothelial regulator | 168667 HGNC:24154 | 1 | 51 | 0 | 0 | 568 | 1,668 |
| PCBP2 poly(rC) binding protein 2 | 5094 HGNC:8648 | 1 | 23 | 0 | 0 | 1,181 | 1,668 |
| GARS1 glycyl-tRNA synthetase 1 | 2617 HGNC:4162 | 1 | 40 | 0 | 0 | 996 | 1,667 |
| PRRX1 paired related homeobox 1 | 5396 HGNC:9142 | 1 | 26 | 0 | 0 | 1,372 | 1,667 |
| USP14 ubiquitin specific peptidase 14 | 9097 HGNC:12612 | 1 | 37 | 0 | 0 | 901 | 1,667 |
| ATP5F1B ATP synthase F1 subunit beta | 506 HGNC:830 | 1 | 58 | 0 | 0 | 1,081 | 1,666 |
| CYP26A1 cytochrome P450 family 26 subfamily A member 1 | 1592 HGNC:2603 | 1 | 12 | 1 | 4 | 1,085 | 1,665 |
| ST6GAL1 ST6 beta-galactoside alpha-2,6-sialyltransferase 1 | 6480 HGNC:10860 | 1 | 217 | 0 | 0 | 1,029 | 1,665 |
| DAB2 DAB adaptor protein 2 | 1601 HGNC:2662 | 1 | 23 | 0 | 0 | 1,467 | 1,661 |
| TUFM Tu translation elongation factor, mitochondrial | 7284 HGNC:12420 | 1 | 18 | 0 | 0 | 1,255 | 1,661 |
| LRP4 LDL receptor related protein 4 | 4038 HGNC:6696 | 1 | 31 | 0 | 0 | 817 | 1,660 |
| WNT7B Wnt family member 7B | 7477 HGNC:12787 | 1 | 60 | 0 | 0 | 1,238 | 1,660 |
| BCKDHA branched chain keto acid dehydrogenase E1 subunit alpha | 593 HGNC:986 | 1 | 35 | 0 | 0 | 1,126 | 1,659 |
| CHRM2 cholinergic receptor muscarinic 2 | 1129 HGNC:1951 | 1 | 78 | 31 | 500 | 1,251 | 1,659 |
Code
curl "https://conductscience.org/api/genes/v1?page=175"
Response
The first 2 of this page's 20 results. GET /api/genes/v1?page=175
{
"data": {
"total": 193990,
"results": [
{
"id": "4818",
"title": "NKG7: natural killer cell granule protein 7",
"summary": "NCBI Gene 4818. 1 protein, 38 patents, 0 drugs, 0 trials, 1,401 NIH grants and 1,677 papers.",
"record": "/library/genes/4818",
"gene_id": 4818,
"symbol": "NKG7",
"name": "natural killer cell granule protein 7",
"hgnc_id": "HGNC:7830",
"counts": {
"proteins": 1,
"patents": 38,
"drugs": 0,
"trials": 0,
"grants": 1401,
"papers": 1677
}
},
{
"id": "2042",
"title": "EPHA3: EPH receptor A3",
"summary": "NCBI Gene 2042. 1 protein, 93 patents, 2 drugs, 99 trials, 1,326 NIH grants and 1,673 papers.",
"record": "/library/genes/2042",
"gene_id": 2042,
"symbol": "EPHA3",
"name": "EPH receptor A3",
"hgnc_id": "HGNC:3387",
"counts": {
"proteins": 1,
"patents": 93,
"drugs": 2,
"trials": 99,
"grants": 1326,
"papers": 1673
}
}
],
"columns": [
{
"key": "symbol",
"label": "Gene",
"under": "name"
},
{
"key": "id",
"label": "NCBI Gene",
"under": "hgnc_id"
},
{
"key": "counts.proteins",
"label": "Proteins"
},
{
"key": "counts.patents",
"label": "Patents"
},
{
"key": "counts.drugs",
"label": "Drugs"
},
{
"key": "counts.trials",
"label": "Trials"
},
{
"key": "counts.grants",
"label": "NIH grants"
},
{
"key": "counts.papers",
"label": "Papers"
}
],
"order": "Most papers first"
},
"release": "gene-search-2026-11-11-0.2.0",
"terms": [
{
"source": "ClinicalTrials.gov's posted results, through CTTI's AACT",
"license": "ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299",
"notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.",
"short": "Freely available. Acknowledgement requested"
},
{
"source": "ChEMBL, through Open Targets",
"license": "CC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence",
"notice": null,
"short": "CC BY-SA 3.0"
},
{
"source": "ClinicalTrials.gov",
"license": "none stated",
"notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.",
"short": "No license stated"
},
{
"source": "EMBL-EBI's patent proteins",
"license": "EMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: \"EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners\" and \"EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools.\" Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use",
"notice": null,
"short": "No added restrictions. Attribution expected"
},
{
"source": "GenBank's patent files",
"license": "GenBank's patent files. NCBI: \"NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted.\" Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/",
"notice": null,
"short": "No restrictions from NCBI. Submitters may hold rights"
},
{
"source": "HGNC",
"license": "CC0: https://www.genenames.org/about/license/",
"notice": null,
"short": "CC0"
},
{
"source": "NCBI Gene",
"license": "None named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/",
"notice": null,
"short": "Public domain (US government)"
},
{
"source": "NIH's project files and grant-paper links",
"license": "Public domain (NIH RePORTER)",
"notice": null,
"short": "Public domain"
},
{
"source": "Open Targets",
"license": "CC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence",
"notice": null,
"short": "CC0 1.0"
},
{
"source": "PubMed",
"license": "NLM's terms",
"notice": null,
"short": "NLM's terms"
},
{
"source": "PubTator 3",
"license": "Public domain",
"notice": null,
"short": "Public domain"
},
{
"source": "UniProt",
"license": "CC BY 4.0. UniProt's licence file: \"All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy.\" UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license",
"notice": null,
"short": "CC BY 4.0"
}
],
"next": "/api/genes/v1?page=176",
"request_id": "VWYptooC6VUjx3VB"
}Ask about these results. The first 10 go in the prompt.
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov
Search clinical trials by condition, drug, outcome or NCT number, with the results each one posted.
ClinicalTrials.gov
Comparisons of the groups of clinical trials, such as a risk ratio or a number needed to treat, calculated from the counts each trial posted.
Patent publications
Paste a sequence and see the patents that disclose it.
Opens sequences.conductscience.org
For software
Every answer on this page is also JSON, under /api/genes/v1. No key.
GET https://conductscience.org/api/genes/v1?q=p53
Ask an assistant